Eleos Health

What does Eleos sell now?

The homepage calls Eleos the system of action for community-based care. The platform documents each session, reviews every note for compliance and flags revenue at risk before a claim goes out. The vendor says more than 300 community-based care organizations use it.

Documentation covers individual, group, psychiatry and assessment notes, with real-time suggestions. The compliance side advertises automatic scanning of 100 percent of notes for quality improvement and audit teams. A revenue cycle layer adds guardrails before claims plus eligibility and hidden-coverage discovery. A clinical insights agent works inside the workflow on crisis and risk, evidence-based practice, substance use and CCBHC work.

According to a competitor's comparison post, it runs as a browser extension over web-based EHRs. The homepage says only that it is EHR-agnostic and names no EHRs.

Who is behind it?

Alon Joffe is CEO and Alon Rabinovich CTO. Sources conflict on headquarters, with Boston, Waltham and Cambridge in Massachusetts all appearing alongside a presence in Tel Aviv. Founding year is given as 2019 or 2020 depending on the source.

Funding reported by Tracxn and others includes a $40 million Series B announced on September 27, 2023, led by Menlo Ventures, and a $60 million Series C on January 22, 2025, led by Greenfield Partners. Aggregators put the total at about $126 to $128 million. No credible acquisition has been reported.

What about security and compliance?

The security page says Eleos is SOC 2 Type II certified "with HITRUST compliance" and HIPAA compliant, mentions a BAA, and shows ISO 27001 and ISO 27799 badges. The wording is HITRUST compliance and not HITRUST certification, so ask which it is. A third-party report says the full documents sit behind the vendor's trust center. FDA status is not stated.

What does the evidence say?

A 2023 JMIR randomized trial tested an AI platform for behavioral interventions on depression and anxiety symptoms and matches the vendor's randomized trial claim of faster symptom reduction. The authors' ties to the company are not stated. A second 2023 JMIR Formative Research paper describes a machine learning model that predicts therapy homework assignment. The vendor publishes no figures for time saved or symptom reduction.

What do users say?

A competitor, Mentalyc, quoted ratings of about 5.0 on Capterra, Software Advice and GetApp (roughly 21 reviews each) and 4.9 on G2 (12 reviews) in June 2026. The same post collected complaints: interference with a Sensi recording device (Capterra, September 2024), inconsistent prompts (Capterra, March 2025) and heavier correction on the non-audio path (Software Advice, August 2024). Therapists on r/TalkTherapy (2026) and r/socialwork (2025) raised consent concerns, and the post says Eleos terms put recording consent on the clinician.

What does it cost?

Eleos publishes no price. The vendor asks for a demo and builds an organization-level quote, and the Mentalyc post cites a Software Advice reviewer from August 2024 who mentioned sticker shock to management.

How does it compare?

Mentalyc, Lyssn, JotPsych, Supanote, Upheal and Blueprint are the other names in behavioral health documentation. Eleos aims its pitch at organizations and puts compliance review first, per its homepage.

Who is it for?

An agency director with 40 clinicians, a CQI team buried in note audits and a payer denying claims for documentation gaps is the target buyer. A private-practice psychotherapist who just wants shorter notes should look at the smaller scribes. Staff who will be recorded should hear how session audio and note analytics are used before rollout.

The verdict

Eleos earns a serious demo from a behavioral health organization with compliance headaches. Ask for the trust center documents, the HITRUST letter and two reference customers on your EHR.